Jerking Movements In Down Syndrome Signal Rapid Decline
Source: Epilepsia open
Summary
What was studied
Researchers followed 12 adults with Down syndrome who had progressive myoclonus epilepsy in the setting of Alzheimer's disease. This was an 11-year follow-up of the same group first described in 2014, looking at how the condition changed over time.
They tracked symptoms using a 3-stage model. The study also included 2 additional adults with Down syndrome, ages 50 and 58, who had amyloid PET brain scans to document amyloid burden.
What they found
The course of illness was very severe and fairly similar across patients. All 12 patients died during follow-up. The median survival after myoclonus began was 4.2 years, and all patients reached the terminal stage within about 2.5 years on average.
The authors proposed a core pattern of myoclonus, ataxia, and seizures in adults with Down syndrome and Alzheimer's disease. In the 2 people who had amyloid PET scans, the scans showed very high amyloid burden in the brain. The study also reported that 38% of patients had clinical worsening associated with sodium channel blockers or phenobarbital.
Limits of the evidence
This was a very small study from an original cohort of 12 patients, plus only 2 extra scanned cases. There was no comparison group, so the study cannot show from these data alone that amyloid caused the epilepsy pattern or the rapid decline. The proposed disease mechanism and diagnostic criteria are based on the authors' interpretation and need confirmation in larger studies.
Because the PET scan findings came from only 2 people, it is not clear how well those scan results apply to all patients with this condition. The study also focused on a severe form of epilepsy in adults with Down syndrome, so the findings may not apply to everyone with Down syndrome, Alzheimer's disease, or seizures.
For families and caregivers
For families, this study suggests that new jerking movements called myoclonus in an adult with Down syndrome may be an important warning sign of advanced brain disease and a fast-changing illness course. It may help explain why doctors take these symptoms seriously and may talk about prognosis and care planning early.
The study also highlights a medication safety point: some seizure medicines were associated with worsening symptoms in this syndrome. Families can ask the care team how the seizure type was identified and whether the chosen medicines fit this pattern.
What to watch next
Stronger evidence would come from larger studies that confirm the proposed red flags and clarify which anti-seizure treatments are safest and most helpful in adults with Down syndrome and this epilepsy pattern.
Terms in this summary
- myoclonus
- Sudden, brief jerking movements of a muscle or group of muscles.
- progressive myoclonus epilepsy
- A group of epilepsy conditions with seizures and worsening jerking movements over time, often with decline in movement or thinking.
- ataxia
- Problems with balance and coordination.
- amyloid
- A protein that can build up abnormally in the brain in Alzheimer's disease.
- amyloid PET
- A brain scan that can show amyloid buildup in living people.
- sodium channel blockers
- A group of anti-seizure medicines that act on sodium channels; in this study, some were associated with worsening symptoms.
- iatrogenic
- Caused by a medical treatment or medicine rather than by the disease itself.
- GABAergic interneurons
- Brain cells that help calm and control nerve activity.
Free: Seizure First Aid Quick Guide (PDF)
Plus one plain-language weekly digest of new epilepsy research.
Unsubscribe anytime. No medical advice.